参考文献/References:
[1] LEVY M L,BACHARIER L B,BATEMAN E,et al.Key recommendations for primary care from the 2022 Global Initiative for Asthma(GINA)update[J].NPJ Prim Care Respir Med,2023,33(1):7.
[2] VARRICCHI G,FERRI S,PEPYS J,et al.Biologics and airway remodeling in severe asthma[J].Allergy,2022,77(12):3538-3552.
[3] 王强,粟芳,李刚山.定喘汤配合普米克令舒雾化吸入治疗小儿哮喘发作期热哮证临床观察[J].贵州医药,2022,46(4):624-625.
[4] 于鸿,计忠宇,赵辉,等.定喘汤对支气管哮喘大鼠气道重塑及嗜酸粒细胞的影响[J].中国中医急症,2011,20(9):1437-1438.
[5] XING Y M,LI P S,LIU Y.1,25-(OH)2D3 participates and modulates airway remodeling by reducing MGP and TGF-β1 expression in TNF-α-induced airway smooth muscle cells[J].Adv Clin Exp Med,2022,31(2):151-155.
[6] HU W,ZHENG X,LIU J,et al.MicroRNA MiR-130a-3p promotes gastric cancer by targeting Glucosaminyl N-acetyl transferase 4(GCNT4)to regulate the TGF-β1/SMAD3 pathway[J].Bioengineered,2021,12(2):11634-11647.
[7] 李政木,黎同明.定喘汤治疗支气管哮喘的药理学研究[J].中药材,1999,22(8):411-413.
[8] KHALFAOUI L,SYMON F A,COUILLARD S,et al.Airway remodelling rather than cellular infiltration characterizes both type2 cytokine biomarker-high and -low severe asthma[J].Allergy,2022,77(10):2974-2986.
[9] 陈翠仪,吴雷,吕嘉春,等.不同严重程度老年哮喘患者降钙素基因相关肽水平临床研究[J].陕西医学杂志,2021,50(7):861-863,898.
[10] ALABED M,ELEMAM N M,RAMAKRISHNAN R K,et al.Therapeutic effect of statins on airway remodeling during asthma[J].Expert Rev Respir Med,2022,16(1):17-24.
[11] 郭静,刘泮力.肿瘤坏死因子-α、内皮素-1、免疫球蛋白E和血栓素B2水平与肺炎支原体感染老年哮喘患者病情严重程度的关系[J].陕西医学杂志,2022,51(7):863-865,869.
[12] SIDDIQUI S,BACHERT C,BJERMER L,et al.Eosinophils and tissue remodeling:Relevance to airway disease[J].J Allergy Clin Immunol,2023,152(4):841-857.
[13] SELLERS A R,RODDY M R,DARVILLE K K,et al.Dexamethasone for pediatric critical asthma:A multicenter descriptive study[J].J Intensive Care Med,2022,37(11):1520-1527.
[14] 李星,田春燕,王丽洁,等.李竹英教授治疗哮喘经验[J].陕西中医,2022,43(7):936-938.
[15] 柳心.支气管哮喘气道重塑的中医病机理论初探[J].江西中医药,2022,53(2):20-22.
[16] 高辉,刘恭,韩仙菊.黄芩素上调miR-625-5p表达干预支气管哮喘小鼠的机制研究[J].陕西中医,2022,43(7):838-841.
[17] 宋治军,李剑雄,林文桂.黄芩总黄酮改善哮喘模型小鼠气道炎症及对TLR3/TRIF通路表达的影响[J].联勤军事医学,2023,37(11):919-923,952.
[18] 马飞,廖东江,雷玉,等.基于PDE-4靶标的桑白皮提取物桑辛素M对小鼠哮喘模型的治疗作用和机制研究[J].国际呼吸杂志,2018,38(7):485-489.
[19] 陈宏,张明浩,陈群,等.麻黄-细辛药对提取物对哮喘模型小鼠气道重塑的影响[J].广西医学,2023,45(2):162-167.
[20] 薛庆辉.miR-130a-3p通过靶向调节自噬相关蛋白7影响儿童支气管哮喘的Th1/Th2平衡和气道重塑[J].福建医科大学学报,2023,57(4):252-257.
[21] 明是非,康秉南,程建敏.LncRNA PVT1靶向miR-130a-3p对肺炎链球菌感染的肺泡上皮细胞损伤的影响[J].毒理学杂志,2020,34(6):454-459,465.
[22] TIAN X,FEI Q,DU M,et al.MiR-130a-3p regulated TGF-β1-induced epithelial-mesenchymal transition depends on SMAD4 in EC-1 cells[J].Cancer Med,2019,8(3):1197-1208.
[23] YUAN J,ZHANG W.Expression and significance of TGF-β1 in infant asthma model[J].Cell Mol Biol,2022,68(7):51-55.
[24] 李道坤,冯娇梅,刘英文,等.中西医结合治疗婴幼儿哮喘的临床观察[J].保健医学研究与实践,2015,12(2):69,78.
[25] 赵辉,张丽,季辉,等.射干麻黄汤加味对哮喘小鼠TGF-β1的影响[J].成都中医药大学学报,2014,37(3):25-26,30.
相似文献/References:
[1]吕明辉,贾艳平,元国红.清热涤痰定喘汤联合穴位贴敷治疗儿童支气管哮喘安全性及疗效分析[J].陕西中医,2019,(1):25.
LV Minghui,JIA Yanping,YUAN Guohong..Safety and efficacy of Qingre Ditan Dingchuan decoction combined with acupoint sticking in the treatment of bronchial asthma in children[J].,2019,(4):25.
[2]李红芬,毕玲莉,张茂华.小青龙汤联合糖皮质激素对支气管哮喘患儿气道重塑 及相关炎症因子的影响[J].陕西中医,2019,(5):631.
LI Hongfen,BI Lingli,ZHANG Maohua..Effects of Xiaoqinglong decoction combined with glucocorticoid on airway remodeling and related inflammatory factors in children with bronchial asthma[J].,2019,(4):631.
[3]唐徐韵,陈盼碧△.穴位埋线治疗支气管哮喘的实验研究探讨*[J].陕西中医,2019,(12):1789.
[4]冷 静,王艳梅,李 慧△.理肺化瘀方治疗支气管哮喘疗效及对患者血清内IgG、IgA、IgM的变化研究*[J].陕西中医,2020,(5):618.[doi:DOI:10.3969/j.issn.10007369.2020.05.018]
LENG Jing,WANG YanMei,LI Hui..Lifei Huayu decoction in the treatment of bronchial asthma and the change of serum IgG,IgA,IgM in patients[J].,2020,(4):618.[doi:DOI:10.3969/j.issn.10007369.2020.05.018]
[5]王兰香,李卫红,周 瑾,等.消积豁痰汤加减联合糖皮质激素治疗老年支气管哮喘临床研究[J].陕西中医,2021,(6):724.[doi:DOI:10.3969/j.issn.1000-7369.2020.06.011]
[6]何 蕊,程玉峰,李艳彬.射干麻黄汤加减对支气管哮喘疗效及患者炎症反应的影响[J].陕西中医,2021,(9):1211.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.015]
HE Rui,CHENG Yufeng,LI Yanbin.Effect of modified Shegan Mahuang decoction on bronchial asthma and inflammation[J].,2021,(4):1211.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.015]
[7]高 辉,刘 恭,韩仙菊.黄芩素上调miR-625-5p表达干预支气管哮喘小鼠的机制研究[J].陕西中医,2022,(7):838.[doi:DOI:10.3969/j.issn.1000-7369.2022.07.005]
GAO Hui,LIU Gong,HAN Xianju.The mechanism of baicalein up-regulating miR-625-5p expression in bronchial asthma mice[J].,2022,(4):838.[doi:DOI:10.3969/j.issn.1000-7369.2022.07.005]
[8]孟玲玉,黄 燕,包海鹏,等.加味过敏煎对支气管哮喘大鼠嗜酸性粒细胞凋亡及Fas、Bcl-2调节作用的研究[J].陕西中医,2023,(5):562.[doi:DOI:10.3969/j.issn.1000-7369.2023.05.004]
MENG Lingyu,HUANG Yan,BAO Haipeng,et al.Research of Jiawei Guomin decoction on eosinophil apoptosis and the regulation mechanism of Fas,Bcl-2 in bronchial asthma rats[J].,2023,(4):562.[doi:DOI:10.3969/j.issn.1000-7369.2023.05.004]
[9]王 伟,马丽华,鞠 上.投杯汤治疗支气管哮喘疗效及对患者气道重塑和气道炎症的影响[J].陕西中医,2023,(8):1047.[doi:DOI:10.3969/j.issn.1000-7369.2023.08.011]
WANG Wei,MA Lihua,JU Shang.Effect of Toubei decoction on bronchial asthma and its influence on airway remodeling and inflammation[J].,2023,(4):1047.[doi:DOI:10.3969/j.issn.1000-7369.2023.08.011]
[10]季雅楠,田春燕,郭丹丹,等.基于PI3K/Akt信号通路探讨中医药治疗支气管哮喘研究进展[J].陕西中医,2023,(12):1827.[doi:DOI:10.3969/j.issn.1000-7369.2023.12.036]
JI Yanan,TIAN Chunyan,GUO Dandan,et al.Progress in the treatment of bronchial asthma with traditional Chinese medicine based on PI3K/Akt signaling pathway[J].,2023,(4):1827.[doi:DOI:10.3969/j.issn.1000-7369.2023.12.036]